CN Patent

CN112047945B — 螺环吡啶酮衍生物及应用

Assigned to Hangzhou Zehnder Medical Technology Co ltd · Expires 2021-11-12 · 5y expired

What this patent protects

本发明公开了螺环吡啶酮类衍生物，具有通式I所示结构。研究表明，所述螺环吡啶酮类衍生物对甲型病毒RNA聚合酶活性具有较强的抑制作用，可在制备抑制甲型流感病毒RNA聚合酶活性和抗甲型流感药物中的应用。通式I如下：

USPTO Abstract

本发明公开了螺环吡啶酮类衍生物，具有通式I所示结构。研究表明，所述螺环吡啶酮类衍生物对甲型病毒RNA聚合酶活性具有较强的抑制作用，可在制备抑制甲型流感病毒RNA聚合酶活性和抗甲型流感药物中的应用。通式I如下：

Drugs covered by this patent

Patent Metadata

Patent number
CN112047945B
Jurisdiction
CN
Classification
—
Expires
2021-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Zehnder Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.